이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 1994. 3. 11.1 분 읽기
Determination of Regulatory Review Period for Purposes of Patent Extension; PRO OSTEONSUPTM Implant 500 Coralline Hydroxyapatite Bone Void Filler
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) has determined the regulatory review period for PRO OSTEON TM Implant 500 Coralline Hydroxyapatite Bone Void Filler and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Commissioner of Patents and Trademarks, Department of Commerce, for the extension of a patent which claims that medical device.
원본 출처 언어: Federal Register — Health and Human Services원문 발표 열기 →